Medical/Pharmaceuticals

IMPACT IN ACTION: Cure Brain Cancer Foundation Launches Inaugural 5-Year Guardian Trust Early Career Fellowship valued at $575,000

SYDNEY, April 8, 2024 /PRNewswire/ -- In a historic first, Cure Brain Cancer Foundation proudly unveiled the launch of its groundbreaking 5-Year Guardian Trust Early Career Fellowship, valued at$575,000. The Guardian Trust Early Career Fellowship represents a bold commitment to fostering a new g...

2024-04-08 07:00 1180

Antengene Presents Four Preclinical Posters at AACR 2024

SHANGHAI and HONG KONG, April 6, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for canc...

2024-04-06 08:30 3028

HSA approves new asthma indication for GSK's Trelegy Ellipta, the first once-daily single inhaler triple therapy approved for use in the treatment of both asthma and COPD in Singapore

SINGAPORE, April 5, 2024 /PRNewswire/ -- GSK Singapore announced that the Health Sciences Authority (HSA) has approved a new indication and a new strength for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol 'FF/UMEC/VI') for the maintenance treatment of asthma in patients aged 18 yea...

2024-04-05 16:00 2680

IRBM to Disclose Strong Antitumor Efficacy of Novel Preclinical Agents Against Aggressive Brain Tumors and Acute Lymphoblastic Leukemia at AACR

ROME, April 4, 2024 /PRNewswire/ -- IRBM, a leader in the field of drug discovery, announced today that it will be disclosing new data on two of its most promising internal assets at the upcoming American Association for Cancer Research (AACR) Annual Meeting occurring inSan Diego, April 5-10. The...

2024-04-04 21:00 2554

Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market

ZEISS secures regulatory approvals to acquire D.O.R.C.; companies now shift focus to integration implementation, fueling world-class innovation, and driving market expansion strategy for ophthalmic medical devices and surgery.   JENA, Germany and DUBLIN, Calif., April 4, 2024 /PRNewswire/ -- Carl...

2024-04-04 19:00 3600

Human Frontier Science Program: Fellowships Awarded to 59 of the Most Pioneering Postdoctoral Scientists from 28 Nations

STRASBOURG, France, April 4, 2024 /PRNewswire/ -- To foster the next generation of life science research, 59 of the world's top emerging scientists from 28 nations have won 2024 Human Frontier Science Program (HFSP) Fellowships. "Brilliance is not born, it has to be cultivated," said HFSP Chief S...

2024-04-04 17:00 2380

SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership

The companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland, April 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space and a leader in data-driven medicine, today announced a s...

2024-04-04 13:00 1864

MEDLEY Opens Philippines Office to Support Global Growth

MANILA, Philippines, April 4, 2024 /PRNewswire/ -- Medley, Inc. (TSE: 4480) ("MEDLEY"), aJapan-based internet service company, opened its Philippine office in Bonifacio Global City (BGC), Taguig onApril 1st to support continued global growth. The opening of the new office and upcoming operation l...

2024-04-04 10:59 2886

iSono Health Applauded by Frost & Sullivan for Ensuring Patient Comfort and Safety and Providing Quality Imaging and Diagnosis with its iSono Health ATUSA

iSono Health AI ABUS ATUSA enables precise and prompt screening, eliminates delays and the need for trained technicians, provides cost-effective imaging, and improves patient outcomes significantly. SAN ANTONIO, April 3, 2024 /PRNewswire/ -- Recently, Frost & Sullivan assessed the breast ultraso...

2024-04-04 01:00 1787

YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility

GAITHERSBURG, Md., April 3, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2024-04-03 20:00 1544

Tianlong Participated in International Medical Congress of SCO Countries in Kyrgyzstan

BISHKEK, Kyrgyzstan, April 3, 2024 /PRNewswire/ -- The International Medical Congress of the SCO countries was held on 27-29 March inBishkek, Kyrgyzstan, under the theme "Innovations and technologies in the development of cardiology and non-communicable diseases in the countries of the Shanghai C...

2024-04-03 16:16 2066

Human Frontier Science Program: Research Grants Awarded to 108 of the Most Pioneering Life Scientists from 23 Nations

STRASBOURG, France, April 3, 2024 /PRNewswire/ -- Representing only the most daring and truly pioneering life science research, 108 of the world's top scientists from 23 nations have won 2024 Human Frontier Science Program (HFSP) Research Grants. "Excellence isn't enough for us – we support rese...

2024-04-03 15:00 1385

Great Place To Work unveils Top 10 Best Workplaces in Singapore Healthcare and Biopharma™ 2024

SINGAPORE, April 3, 2024 /PRNewswire/ -- Great Place To Work®, the global authority on workplace culture announcedSingapore's top 10 Best Workplaces in Healthcare and Biopharma™  in 2024.

2024-04-03 12:00 1993

RemeGen's Telitacicept (RC18) Granted Fast Track Designation by United States FDA for Treatment of Primary Sjögren's Syndrome

YANTAI, China, April 3, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, obtained Fast Track Designation (FTD) by the United States Food and Drug Administration (FDA) recently for its inno...

2024-04-03 11:14 1514

Samyang Holdings's Croquis® Shows New Clinical Cases of PDO thread lift at AMWC 2024

* Sharing Clinical Cases of "Croquis® at AMWC 2024 in Monaco. * Expand market with proven safety and efficacy, 29 countries worldwide.  * "Croquis®" Lifting Threads with Samyang' 25 years Expertise in Global Biodegradable Suture Threads. SEOUL, South Korea, April 3, 2024 /PRNewswire/ -- Samy...

2024-04-03 09:30 1819

Latvian pharmaceutical manufacturing company Grindeks opens new subsidiaries worldwide

RIGA, Latvia, April 3, 2024 /PRNewswire/ -- The leading pharmaceutical company in the Baltics, Grindeks, is developing new products and reinforcing its position not only in European but also global markets. With determination and innovative approaches, Grindeks continues to enhance the competitiv...

2024-04-03 05:00 1760

TraceLink Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024

TraceLink joins the ranks of Nvidia, YouTube, OpenAI, Novo Nordisk and more BOSTON, April 3, 2024 /PRNewswire/ -- TraceLink has been named to Fast Company 's prestigious list of the World's Most Innovative Companies of 2024. This year's list shines a spotlight on businesses that are shaping their...

2024-04-03 03:22 1414

LifeTech Scientific Corporation Announced 2023 Annual Results: International Business Achieved a Robust Growth, Innovation at the Core to Drive the Solid Development

SHENZHEN, China, April 2, 2024 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "Lifetech", Stock code: 1302.HK), a company specializing in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, together with its subsidiarie...

2024-04-02 22:13 3484

Cognex Launches the World's First 3D Vision System with AI

AI-powered 3D vision system offers fast deployment and reliable inspections for manufacturing automation NATICK, Mass., April 2, 2024 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX), the leader in industrial machine vision, today released the In-Sight® L38 3D Vision System, which combines AI, ...

2024-04-02 20:30 2047

CONCEPT MEDICAL RECEIVES US FDA IDE APPROVAL FOR MAGICTOUCH AVF INDICATION, THEIR FIFTH US CLINICAL STUDY APPROVAL FOR THE MAGICTOUCH PORTFOLIO

TAMPA, Fla., April 2, 2024 /PRNewswire/ -- Concept Medical has been granted 'IDE Approval' from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter, to initiate a clinical study for the treatment of stenotic lesions of Arteriovenous Fis...

2024-04-02 17:33 2052
123456 ... 382